APA (7th ed.) Citation

D, L., X, G., J, L., Y, H., WL, Z., F, W., . . . W, W. (2026). Zoledronic acid enhances the antitumor efficacy of the PSMA CAR-T cells for bone tumors, but impedes the ability to control metastases of prostate cancer in mice. Cancer gene therapy. https://doi.org/10.1038/s41417-026-01025-8

Chicago Style (17th ed.) Citation

D, Li, et al. "Zoledronic Acid Enhances the Antitumor Efficacy of the PSMA CAR-T Cells for Bone Tumors, but Impedes the Ability to Control Metastases of Prostate Cancer in Mice." Cancer Gene Therapy 2026. https://doi.org/10.1038/s41417-026-01025-8.

MLA (9th ed.) Citation

D, Li, et al. "Zoledronic Acid Enhances the Antitumor Efficacy of the PSMA CAR-T Cells for Bone Tumors, but Impedes the Ability to Control Metastases of Prostate Cancer in Mice." Cancer Gene Therapy, 2026, https://doi.org/10.1038/s41417-026-01025-8.